There is evidence that mesenchymal stem cells (MSCs) can differentiate towards an intervertebral disc (IVD)-like phenotype. We compared the standard chondrogenic protocol using transforming growth factor beta-1 (TGFß) to the effects of hypoxia, growth and differentiation factor-5 (GDF5), and coculture with bovine nucleus pulposus cells (bNPC). The effi cacy of molecules recently discovered as possible nucleus pulposus (NP) markers to differentiate between chondrogenic and IVD-like differentiation was evaluated. MSCs were isolated from human bone marrow and encapsulated in alginate beads. Beads were cultured in DMEM (control) supplemented with TGFß or GDF5 or under indirect coculture with bNPC. All groups were incubated at low (2 %) or normal (20 %) oxygen tension for 28 days. Hypoxia increased aggrecan and collagen II gene expression in all groups. The hypoxic GDF5 and TGFß groups demonstrated most increased aggrecan and collagen II mRNA levels and glycosaminoglycan accumulation. Collagen I and X were most up-regulated in the TGFß groups. From the NP markers, cytokeratin-19 was expressed to highest extent in the hypoxic GDF5 groups; lowest expression was observed in the TGFß group. Levels of forkhead box F1 were down-regulated by TGFß and up-regulated by coculture with bNPC. Carbonic anhydrase 12 was also down-regulated in the TGFß group and showed highest expression in the GDF5 group cocultured with bNPC under hypoxia. Trends in gene expression regulation were confi rmed on the protein level using immunohistochemistry. We conclude that hypoxia and GDF5 may be suitable for directing MSCs towards the IVD-like phenotype.
Introduction
The intervertebral disc (IVD) functions to absorb loads on the spinal column and to provide the flexibility required to allow fl exion and extension of the spine. IVD degeneration is associated with a degradation of extracellular matrix molecules, leading to a dehydration of the highly hydrated central nucleus pulposus (NP). The mechanical instability resulting from structural failure is believed to cause pain and disability in a large number of patients (Adams and Roughley, 2006) . Biological approaches including cell therapy and tissue engineering have been investigated as promising treatment strategies . Among those, mesenchymal stem cells (MSCs) hold great potential for regenerative therapy, since they have the ability to differentiate into various cell types of the mesenchymal lineage (Pittenger et al., 1999; Chamberlain et al., 2007) and can be harvested and cultured relatively easily. Therapeutic application of MSCs for bone and cartilage repair and regeneration has widely been investigated (Salgado et al., 2006) , and recent studies have demonstrated the feasibility of MSC injection to reverse or retard degenerative disorders of the IVD (Sakai et al., 2008; Ganey et al., 2009; . In fact there is growing evidence from both in vitro and in vivo studies that MSCs can differentiate into NP-like cells of the IVD (Le Maitre et al., 2009; . However, while standard procedures have been established for in vitro differentiation of MSCs into osteoblastic or chondrocytic cells (Caplan, 1991; Pittenger et al., 1999) , no such protocol exists to date for direction of MSCs towards the NP cell phenotype; though a fundamental requirement for tissue engineering or regeneration both in vitro and in vivo is a population of cells capable of forming the appropriate target tissue.
Several approaches have been proposed for in vitro differentiation of MSCs into IVD or NP-like cells (Leung et al., 2006; Paesold et al., 2007; Sakai, 2008) . Given that the cells that populate the NP have been recognised to closely resemble the cells of cartilaginous tissues, identical or similar culture conditions have been applied for chondrogenic and disc-like differentiation of MSCs. These include culture in a three-dimensional environment, growth and differentiation factor supplementation, low oxygen tension, hydrostatic pressure as mechanical stimulus, coculture with IVD cells, or a combination of these mediators. For example, when rat MSCs were cultured in alginate beads under hypoxic conditions and supplementation of transforming growth factor beta
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JV Stoyanov et al. Hypoxia and GDF5 in MSC differentiation (TGFβ) , differentiation towards a phenotype consistent with that of NP cells was observed (Risbud et al., 2004) . Besides TGFβ, routinely used as standard chondrogenic factor, growth and differentiation factor 5 (GDF5), also known as cartilage-derived morphogenetic protein-1 (CDMP-1), had previously been shown not only to play a key role in skeletal development (Francis-West et al., 1999) but also to induce chondrogenic differentiation of MSCs (Bai et al., 2004; Feng et al., 2008) . Furthermore, coculture with human NP cells was shown to induce differentiation of human bone marrow derived MSCs as assessed by signifi cant increases in chondrogenic gene expression and extracellular matrix production (Richardson et al., 2006; Sobajima et al., 2008) . However, only a direct comparison of the capability of various environmental factors to induce an NPlike phenotype in MSCs can evaluate distinctions in differentiation potential. In the present study we measured the influence of hypoxia on human bone marrow derived MSCs in three dimensional alginate cultures as a modulator of the effects of transforming growth factor beta 1 (TGFβ1), GDF5 and coculture with bovine nucleus pulposus cells (bNPC), for the purpose of inducing an IVD-like phenotype. Hypoxic conditions applying 2 % oxygen tension were chosen to mimic the avascular hypoxic environment of the NP tissue; previous studies had shown enhanced chondrogenic and NP-like differentiation in MSCs cultured under 2-3 % oxygen (Risbud et al., 2004; Felka et al., 2009; Baumgartner et al., 2010; Markway et al., 2010) . We hypothesised that different combinations of hypoxia with growth factors or coculture may have synergistic or modulatory effects and some of these combinations may result in a differentiation pattern approaching that of IVD cells. In order to potentially distinguish between chondrogenic and IVD-like differentiation, we not only monitored the expression of characteristic chondrogenic genes and glycosaminoglycan (GAG) accumulation, but also the expression of genes that had been found up-regulated in NP compared to annulus fi brosus cells or articular chondrocytes, namely cytokeratin 19 (KRT19) Rutges et al., 2010) , forkhead box F1 (FOXF1), and carbonic anhydrase 12 (CA12) (Minogue et al., 2010) . The intermediate fi lament protein KRT19, the transcription factor FOXF1, and the carbonic anhydrase CA12 have been suggested as potential NP markers, although their roles in IVD structure and function have barely been investigated yet. These molecules were, however, identifi ed based on large scale gene expression profi ling of NP cells in comparison to chondrocytes Minogue et al., 2010; Rutges et al., 2010) .
Materials and Methods

Isolation of MSCs from human bone marrow
Informed consent was obtained from each donor and approval was given by the ethics committee of canton Luzern to collect bone marrow from the iliac crest during routine surgery (n = 3; average age 29.7 years). Bone marrow aspirate was diluted in 3.8 % sodium citrate and 1x phosphate buffered saline (PBS) and filtered through a 100 μm cell strainer (Falcon, BD Bioscience, Franklin Lakes, NJ, USA). Mononuclear cells fraction was isolated by centrifugation at 800 g for 20 min in a Leucosep tube (Greiner, Langenthal, Switzerland) over Ficoll gradient (density 1.077 g/mL; GE Healthcare, Glattbrugg, Switzerland). Cells were washed with PBS, centrifuged at 400 g and re-suspended in PBS, then counted using trypan blue dye (C-Chip Typ Neubauer, Zeiss, Jena, Germany). Cells were placed in a T150 tissue culture fl ask in NH-Expansion medium (Miltenyi, Bergisch Gladbach, Germany) at 37 °C in a humid atmosphere containing 5 % CO 2 . After 48 h non-adherent cells were discarded, whereas adherent cells were cultured in DMEM/F12 + GlutaMAX, supplemented with 10 % foetal bovine serum (FBS), (100 units/mL) penicillin / (100 μg/mL) streptomycin, 2.5 ng/mL Amphotericin B (all Gibco/Invitrogen, Basel, Switzerland) and 5 ng/mL recombinant basic FGF-2 (Peprotech, London, UK) with medium changed 3 times per week. At 70 % confl uence, cells were harvested by dissociation with 0.05 % trypsin and expanded to another passage in T300 fl asks until required cell numbers were obtained. MSCs (passages 3 and 4) were then directly used in three dimensional cultures or cryopreserved in liquid nitrogen.
Isolation of nucleus pulposus cells from bovine caudal discs
Nucleus pulposus cells (bNPC) were derived from fresh caudal IVDs (6-12 months old) of bovine tails obtained from a local abattoir. NP tissue was dissected and digested initially in 0.19 % pronase (Roche, Basel, Switzerland) solution for 1 h with a subsequent 14 h digestion in 0.4 % collagenase II (Worthington, Lakewood, NJ, USA) solution in Dulbecco's Modified Eagles Medium (DMEM, Gibco) containing 10 % FBS and antibiotics. The digested tissue / cell suspension was passed through a 100 μm cell strainer to remove tissue debris and cell count and viability were determined using trypan blue assay and haemocytometer cell counting. Then the cells were pelleted by centrifugation at 400 g for 5 min, after which they were transferred to three dimensional alginate culture.
Three dimensional MSCs culture and coculture with bNPC MSCs and bNPC were encapsulated in three dimensional 1.2 % alginate (Fluka, Basel, Switzerland) beads at a density of 4x10 6 cells/mL (approximately 8x10 4 cells per bead) by dropping the alginate solution through a 22G needle into a 0.9 % NaCl and 102 mM CaCl 2 solution (Maldonado and Oegema, 1992) . The beads were assigned to six separate groups: (1) Basal medium (BM), consisting of Dulbecco's Modifi ed Eagle's Medium (DMEM) supplemented with 50 μg/mL ascorbic acid, 2.5 % FBS and ITS+ (Gibco); (2) GDF, consisting of BM and 100 ng/mL rhGDF5; (3) GDF/ Dex, consisting of BM, 100 ng/mL rhGDF5 and 40 ng/mL dexamethasone; (4) Chondrogenic (TGF), consisting of BM, 10 ng/mL TGFβ1 and 40 ng/mL dexamethasone; (5) NPC, an indirect coculture of bNPC and MSC, ratio 1:1 in BM, where bNPC were grown in cell culture inserts with 0.4 μm high pore density PET membranes (BD Falcon); (6) GDF/NPC, an indirect coculture as described above JV Stoyanov et al. Hypoxia and GDF5 in MSC differentiation in BM containing 100 ng/mL rhGDF5. For groups (5) and (6) 12-well plates were used, with beads containing MSCs placed at the bottom of the well and beads containing bNPC placed into the culture well insert as previously illustrated (Gantenbein-Ritter et al., 2011) . All groups were incubated at normal (20 %) or low (2 %) oxygen tension (total of 12 groups) and sampled at days 0, 7, 14 and 28.
RNA and protein isolation, cDNA synthesis and real time PCR RNA was isolated from alginate beads homogenised (Dispomix) in lysis buffer using Aurum Total Mini Kit (Bio-Rad, Basel, Switzerland) and further following the manufacturer's instructions, including a DNase treatment step. Total RNA (≤ 500 ng) was used to synthesise cDNA utilising VILO cDNA Synthesis Kit (Invitrogen) in a reaction volume of 20 μL, after which cDNA was diluted 1:10 with RNAse-free water and stored at -20 °C. The diluted cDNA (5 μL) was mixed with the PCR reaction solution (IQ SYBR Green Supermix, Bio-Rad) containing 0.25 μM specifi c primers for 18S rRNA, aggrecan (ACAN), collagen type I (COL1A1), and collagen type II (COL2A1) ( Table 1) . Reactions (25 μL) were carried out in triplicates in a real time thermal cycler CFX96 (Bio-Rad). Specifi city of the amplifi cation products was controlled by performing a melting curve analysis after each reaction. For SOX9, collagen type X (COL10A1) and the potential NP cell differentiation markers cytokeratin 19 (KRT19), forkhead box F1 (FOXF1), and carbonic anhydrase 12 (CA12), TaqMan® method was applied using Gene Expression Master Mix, Gene Expression Assays (both from Applied Biosystems, Rotkreuz, Switzerland) and primers/probes listed in Table 2 . PCR was performed with the GeneAmp 7500 Real Time PCR instrument (Applied Biosystems) under standard thermal conditions. Gene expression was calculated by the 2 -ΔΔCt method (Livak and Schmittgen, 2001) , normalizing data to 18S rRNA as the endogenous control. The endogenous control was selected based on pilot experiments that confi rmed the stability of this housekeeping gene under the different experimental conditions (data not shown). Additionally, the relative ACAN / COL2 ratio was calculated by the term 2 -(∆CtACAN-∆CtCOL2) (Mwale et al., 2004; Gantenbein-Ritter et al., 2011) .
Protein isolation and immunoblotting
Protein was isolated from the lysates used for RNA isolation by pooling the Aurum column fl ow-through and fi rst low stringency washing solution, precipitating for at least 14 
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h at -20 °C , centrifugation at 15,000 g for 15 min, washing with 70 % ethanol and fi nally re-suspending the pellet in Lämmli sample application buffer. These samples were boiled at 99 °C for 10 min, separated by 10 % SDS-PAGE, and transferred to a 0.45 μm nitrocellulose membrane by wet electro-transfer (Bio-Rad); membranes were blocked in 5 % bovine serum albumin in PBS and incubated with monoclonal antibodies against aggrecan (1:1000, AHP0022, Biosource, Nivelles, Belgium) or collagen type II (1:200; II-II6B3) and actin (1:1000, JLA20-s), (both from Developmental Studies Hybridoma Bank, University of Iowa, Ames, USA) overnight at 4 °C . Then membranes were washed three times in PBS, incubated with goat antimouse horseradish peroxidase conjugated IgG (Bethyl Inc., Luzern, Switzerland) for 1 h at 20 °C , washed again and developed with tetramethylbenzidine Small Particle HRP Membrane chromogenic substrate (BioFX, Luzern, Switzerland) or Chemiluminescence Kit for Horseradish Peroxidase (Applichem).
Glycosaminoglycan and DNA quantifi cation
Glycosaminoglycan (GAG) accumulation was quantifi ed with dimethylmethylene blue (DMMB) (Farndale et al., 1986) binding assay after overnight digestion of three alginate beads per sample at 60 °C with 125 μg/mL papain in 5 mM L-cysteine HCL, 5 mM Na-citrate, 150 mM NaCl, 5 mM EDTA. The GAG accumulation was determined by binding to DMMB blue (Fluka) at pH 1.5 (for reduced alginate background) (Enobakhare et al., 1996) . Within 5 min absorption was measured at 595 nm and quantifi ed against chondroitin sulphate (Sigma-Aldrich, St. Louis, MO, USA) reference standards.
Total double stranded DNA was measured for each sample after papain digestion. The amount of DNA was determined using Quant-iT ds HS DNA Assay Kit (Molecular Probes, Invitrogen, Basel, Switzerland) and Qubit fluorometer (Invitrogen). All test groups were analysed in triplicates.
Immunohistochemistry and histological analysis
Beads were harvested after 28 days of culture in the different media, in normoxic and hypoxic cultures, fi xed in 70 % methanol, embedded in OCT Tissue Tek (Miles Laboratories, Inc., Elkhart. IN, USA) compound for 30 min and then frozen at -80 °C. Constructs were subsequently cryosectioned at 30 μm thickness using a cryostat (CM 1850, Leica).
Immunohistochemical analysis was used to detect collagen type II and cytokeratin 19 accumulation. Endogenous peroxidases were quenched by 3 % H 2 O 2 in 0.1 mM CaCl 2 at room temperature for 10 min, and washed with 0.1 mM CaCl 2 . Before incubation with anti-collagen type II antibody, sections were pre-treated for 40 min with 2500 U/mL hyaluronidase (Sigma-Aldrich) in 0.1 mM CaCl 2 at 37 °C. Non-specifi c background was blocked with PBS containing 1 mg/mL BSA, 10 % FBS and 0.1 % Triton (Applichem) for 1 h. Sections were incubated overnight at 4 °C with monoclonal mouse anti-collagen type II antibody (1:20; II-II6B3, Development Studies Hybridoma Bank) and cytokeratin 19 (1:500; 628501, BioLegend) in blocking solution. After washing with 0.1 mM CaCl 2 , sections were incubated with a secondary biotinylated goat anti-mouse antibody (1:200; B0529, Sigma-Aldrich), and then with streptavidin-peroxidase polymer (1:200; S2438, Sigma) for 45 min at room temperature. Collagen type II and cytokeratin 19 were visualised by reaction with 0.075 % solution of 3-amino-9-ethylcarbazole (AEC, Applichem) in 0.01 % H 2 O 2 . Sections were mounted with 70 % Glycerol (Applichem) and examined by light microscopy.
Alternatively, for CA12 immunohistochemistry, beads were fi xed in 70 % methanol and embedded in paraffi n. Sections were deparaffi nised, treated with 3 % hydrogen peroxide in methanol for 30 min and then with heated (95 °C) citrate buffer (10 mM sodium citrate, 0.05 % Tween20, pH 6.0) for 15 min for antigen retrieval. Then they were blocked with 5 % normal horse serum for 1 h, and were incubated with rabbit anti-CA12 precursor antibody (cat. no. HPA008773, 0.04 mg/mL, Prestige Antibodies, SigmaAldrich) at a 1:60 dilution over night at 4 °C. Negative control sections were incubated without primary antibody. Biotinylated secondary anti-rabbit antibody (dilution 1:200; Vectastain ABC-kit Elite, Vector Laboratories, Burlingame, CA, USA) was applied, followed by ABC complex, and chromogen development using diaminobenzidine (DAB Kit, cat. no. SK-4100, Vector Laboratories). Sections were counterstained with Mayer's haematoxylin.
Histological detection of GAG accumulation was carried out by Alcian Blue staining. Sections were stained overnight with 0.4 % alcian blue dissolved in 0.01 % H 2 SO 4 (Applichem) and 0.5 M guanidine hydrochloride (Fluka). Next, sections were washed for 30 min in 40 % DMSO and 0.05 M MgCl 2 (both from Applichem), mounted with 70 % Glycerol and examined by light microscopy.
Statistical analysis
Wilcoxon non-parametric test for dependent data (PASW Statistics v.18) was used to compare gene expression, GAG and DNA. A signifi cance value of p < 0.05 was specifi ed. Data from three human donors, each run in triplicate samples, are presented. Values are reported as mean ± SD.
Results
Chondrogenic gene expression
The mRNA expression of aggrecan was near the detection limit in normoxic control cultures (BM group) at early time points, which made the normoxic control group unsuitable as the reference group for data normalisation. Gene expression results were therefore expressed relative to the normoxic chondrogenic (TGF/Dex) group, which showed a robust expression of aggrecan already at day 7; this allowed for more reliable and accurate calculation. In the TGF/ Dex group, both in normoxia and hypoxia, human MSCs in three-dimensional alginate culture showed a trend of time-dependent increase of all tested chondrogenic genes except collagen type I (Fig. 1A-D) . In normoxic cultures, the GDF/Dex group showed highest aggrecan expression at day 7, whereas at later time points the levels of the TGF/ Dex group were highest (200 fold up-regulation on day 28 compared to day 7) (Fig. 1A) . Hypoxic culture increased aggrecan gene expression compared to the corresponding 
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normoxic culture in all groups except the bNPC group at early time points. The hypoxic GDF/Dex and TGF/Dex groups demonstrated most increased aggrecan mRNA levels throughout culture with almost 1400 and 1200 fold induction at 28 d. All groups apart from the normoxic (day 7 and day 14) and hypoxic (day 7) bNPC and GDF/ NPC showed a signifi cant difference (p < 0.05) compared to the normoxic BM group within the same time point. Collagen type II expression followed similar trends (Fig.  1B) . In normoxia, no clear differences were observed at early time points, while a 5,000 fold induction was noted in the TGF/Dex group at day 28. Hypoxic culture led to increased collagen II expression at day 14 and day 28 in all groups except the bNPC group. With >40,000 fold increase at day 28, the TGF/Dex group in hypoxia showed the highest relative expression, followed by the GDF/Dex group in hypoxia with >9,000 fold induction.
As with aggrecan, all groups apart from the bNPC group in normoxia (day 7) and hypoxia (day 28) and the GDF/ NPC group in normoxia (day 7 and day 14), showed a signifi cant difference (p < 0.05) compared to the BM group in normoxia. Coculture with bNPC neither enhanced chondrogenic genes in normoxic nor in hypoxic conditions; however, in the presence of GDF5, chondrogenic profi les were slightly increased. The expression of collagen type I was highest in the TGF/Dex group in hypoxia and lowest in the GDF/Dex group both in normoxia and hypoxia by day 28 (Fig. 1C) . At the level of chondrogenic regulation, the expression of Sox9 was increased systemically in hypoxia with highest level (8.5 fold increase) in the hypoxic TGF/ Dex group at day 28 (Fig. 1D) . With two fold induction in the hypoxic BM group the Sox9 levels were similar to the normoxic levels in TGF/Dex and GDF/Dex groups at day 28 of culture. The aggrecan-to-collagen II mRNA expression ratio was assessed, since it had previously been reported that the ratio of GAG to hydroxyproline could be used to distinguish NP from cartilage tissue; specifi cally, a markedly higher ratio had been found for the NP compared to cartilage (Mwale et al., 2004) . The ratio was measured at the gene expression level since (i) hydroxyproline values that are generally lower than GAG amounts were 
mostly below the limit of quantifi cation of the assay and (ii) the expression of collagen type II was considered more relevant than the expression of total collagen. Relative ratios of gene expression, calculated as 2
, showed highest values (20:1-30:1) in the GDF/Dex groups both in normoxia and hypoxia compared to the lowest relative value of 1:1 in the hypoxic TGF/Dex group ( Fig.  2A) .
The expression of the hypertrophic marker collagen type X was most up-regulated in the TGF/Dex group compared to the normoxic BM group in both normoxia (~300 fold) and hypoxia (1400 fold); generally all groups expressed more collagen type X mRNA at low compared to normal oxygen conditions (Fig. 2B ).
Gene expression of NP markers
By day 28, cytokeratin 19 (KRT19) mRNA was expressed to highest extent in the control and GDF groups in hypoxic conditions; lowest expression was observed in the TGF/Dex group in normoxia. Generally, the KRT19 levels increased under hypoxia, whereas the presence of dexamethasone negatively infl uenced the levels of KRT19 Hypoxia and GDF5 in MSC differentiation both in hypoxia and normoxia (Fig. 3A) . Forkhead box F1 (FOXF1) mRNA was enhanced by coculture with bNPC and was signifi cantly down-regulated in the chondrogenic TGF/Dex group (Fig. 3B) . Similarly, carbonic anhydrase 12 (CA12) mRNA expression was also reduced by TGF/ Dex and to a lesser extent by GDF/Dex supplementation, whereas coculture with bNPC or hypoxic conditions appeared to increase the CA12 gene expression (Fig. 3C) .
Total GAG and DNA content
In normoxia the total amount of DNA dropped over the four weeks culture time in all samples, while under hypoxia the DNA content remained stable in the GDF/Dex and TGF/ Dex groups over the same time (Fig. 4A) . The detection of solubilised GAG by DMMB chromogenic assay was time dependent and was highest in the TGF/Dex groups at day 28 (Fig. 4B) . While hypoxia in the absence of growth factors did not induce GAG accumulation, there was a marked increase over normoxia in the TGF/Dex and GDF/Dex groups. Specifi cally, the overall accumulation of GAG in the TGF/Dex group after 28 days of culture showed a signifi cant (p < 0.05) six-fold increase in normoxia and 18-fold increase in hypoxia, compared to the control group in normoxia. The hypoxic GDF/Dex group at the same time point showed a 5.5-fold increase compared to the control group; interestingly there was no increase in proteoglycan content in the GDF/Dex group under normal oxygen conditions.
Matrix and marker protein accumulation
Immunoblotting of the protein in the fl ow-through of RNA extraction lysates was used to detect aggrecan and collagen type II using monoclonal antibodies. Using this method, aggrecan was shown to be strongly expressed in the GDF/Dex group and collagen type II was detected in hypoxia, in the TGF/Dex and GDF/Dex groups (Fig. 5) . Immunoblotting therefore confi rmed the aggrecan-tocollagen II results from the RT-PCR and identifi ed the strongest aggrecan producing sample at day 28.
Histological staining of alginate bead sections with Alcian blue confi rmed increased GAG accumulation under hypoxia at day 28, with the GDF/Dex group showing stronger and more homogenous staining than the TGF/Dex group (Fig. 6, top panel) . This was further corroborated by most intense immunostaining for aggrecan in the hypoxic GDF/Dex group, followed by the hypoxic TGF/Dex group (data not shown).
Immunohistological detection of collagen type II revealed most pronounced staining in sections of alginate beads cultured under hypoxia in the presence of GDF/Dex and especially TGF/Dex (Fig. 6, bottom  panel) . Furthermore, immunohistochemical staining also demonstrated enhanced expression of KRT19 protein in hypoxic cultures supplemented with growth factors and more intense CA12 immunoreactivity in hypoxic compared to normoxic cultures (Fig. 7) . With respect to the typical chondrogenic markers aggrecan, type II collagen, Sox9, and glycosaminoglycans, TGF/Dex supplementation demonstrated the expected pronounced chondrogenic gene up-regulation and GAG accumulation. Treatment with GDF5/Dex showed similar effects, although with different collagen to aggrecan ratios, while hypoxic conditions generally enhanced the chondrogenic response. These benefi cial effects of low oxygen tension in terms of chondrogenic or NP-like differentiation of MSCs are in agreement with previously described data and are likely to refl ect the in vivo situation that is characterised by physiologically low oxygen concentration in NP and cartilaginous tissues (Risbud et al., 2004; Baumgartner et al., 2010; Markway et al., 2010) .
For differentiation towards chondrogenic and NP-like cells GDF5 application shows several advantages over TGF-β, including the depressed expression of collagen type I and collagen type X. Collagen type X is a marker of the hypertrophic phenotype; hence a suppression of type X collagen expression would be of advantage for the development and preservation of a chondrogenic or disc-like phenotype. Treatment of MSCs with TGFβ in vitro generally leads to a hypertrophic rather than a stable chondrogenic phenotype. This is associated with endochondral ossification and calcification processes (Pelttari et al., 2006; Pelttari et al., 2008) . With respect to NP-like differentiation, the enhanced aggrecan to collagen II gene expression ratio is an additional benefi t of GDF5 (Gantenbein-Ritter et al., 2011) ; the proportion of glycosaminoglycan to collagen is markedly higher in the NP than in cartilage and can provide a reliable measure to differentiate between these two tissues (Mwale et al., 2004) . The elevated proteoglycan (or specifi cally aggrecan) to collagen II ratios in cultures supplemented with GDF5 compared to TGF-β were also observed at the protein level; the slight divergences between gene and protein expression patterns may be attributed to the different sensitivities between mRNA and protein detection methods, different post-translational regulations, and/or delayed protein compared to mRNA synthesis. The chondrogenic potential of GDF5 has previously been demonstrated (Bai et al., 2004; Feng et al., 2008) . Furthermore, due to its benefi cial effects on both NP cells and MSCs GDF5 has been proposed as a promising factor for NP tissue engineering (Yang and Li, 2009) .
Although the phenotype of IVD and in particular NP cells is closely related to the chondrocytic phenotype and the cellular environment and extracellular matrix composition are similar between chondrocytes and NP cells, distinct differences have been described. Genes preferably expressed in the NP may be valuable for monitoring expression changes in MSCs in response to environmental stimuli that are likely to induce an NPlike phenotype. It is hypothesised that molecules that are expressed signifi cantly more highly in native disc cells compared to chondrocytes would be up-regulated during the course of NP-like in contrast to chondrogenic differentiation. Cytokeratin-19 was identifi ed as an NP marker in rat cells and was demonstrated to be expressed also in human NP cells Rutges et al., 2010; Weiler et al., 2010) . Results of the present study indicate that low oxygen tension can induce KRT19 expression in MSCs. Certain cytokeratins including KRT19 have been identifi ed as notochordal cell markers (Weiler et al., 2010) . However there is a body of evidence showing that all NP cells are of identical origin (Risbud et al., 2010) ; hence the presence of KRT19 also in non-notochordal NP cells is in agreement with the latter hypothesis. Furthermore the gene expression differences of 2-3 orders of magnitude between the normoxic TGFβ/Dex treated and hypoxic cultured MSCs may allow indications about their differentiation state. Furthermore, immunohistochemistry confirmed the mRNA data of increased expression of KRT19 under hypoxia in the GDF/Dex and TGF/Dex groups, although not in the control group.
Similar to the KRT19 mRNA expression, the levels of forkhead box F1 (FOXF1) and carbonic anhydrase 12 (CA12), two other potential molecular markers for NP cells, were also decreased in response to the standard chondrogenic supplements TGF-β/Dex. FOXF1 and CA12 were previously reported to be expressed at increased levels in human IVD in comparison to articular cartilage cells (Minogue et al., 2010) . Interestingly, indirect coculture with NPC induced an up-regulation of these genes, suggesting that soluble factors released by the NPC may promote an NP-like phenotype in MSCs (Kim et al., 2009; Gantenbein-Ritter et al., 2011) . Interaction between NPC and MSC by paracrine stimulation has been described before, although higher numbers of NPC may be necessary to signifi cantly induce a chondrogenic phenotype in coculture without cell-cell contact (Yang et al., 2008) . FOXF1 is a member of the forkhead box transcription factors. It has been identifi ed as a mesenchyme-specifi c marker with essential functions in organ development and repair and in mesenchymal cell migration (Mahlapuu et al., 1998; Malin et al., 2007) .
CA12 expression was also increased by low oxygen conditions. Immunohistochemistry confi rmed the enhanced levels of CA12 protein under hypoxia in all experimental groups. This is consistent with fi ndings of hypoxia induced carbonic anhydrase up-regulation in tumour cells (Wykoff et al., 2000; Ivanov et al., 2001) . In particular, hypoxiainducible CA9 and CA12 have been shown to promote cell survival and growth through maintenance of the intracellular pH (Chiche et al., 2009) . Hypoxia-induced CA12 mediated pH regulation may also play a major role in NP cell and MSC survival.
However, while this study provides further insight in the expression and regulation of these potential new NP marker genes during MSCs differentiation, the functional role of these molecules in IVD homeostasis requires further investigation. Moreover, although clear and signifi cant JV Stoyanov et al. Hypoxia and GDF5 in MSC differentiation trends are observed, the low number of donors is a limitation of this study. An indirect coculture system was chosen in this study, which facilitates the recovery of the MSCs after culture for gene expression analysis. Coculture with NPC increased the expression of CA12 and FOXF1 and also moderately aggrecan and collagen II in MSC after 28 days at the mRNA level. Several recent studies have shown that coculture with NPC can induce an NP-like phenotype in MSC (Vadala et al., 2008; Miyamoto et al., 2010; Strassburg et al., 2010) . Interactions between human NP cells and adipose tissue derived stem cells were also studied in indirect coculture, whereby chondrogenic differentiation of the adipose stem cells was achieved when both cell types were maintained in micromass culture (Lu et al., 2007) . Moreover, MSC have been reported to enhance the metabolic activity of NP cells (Strassburg et al., 2010; Watanabe et al., 2010) . This has implications for MSC-based regenerative therapy, where implanted stem cells may activate endogenous NP cells; while the latter in turn may promote differentiation of the regenerative stem cells Miyamoto et al., 2010) .
In conclusion, all the investigated stimuli -hypoxia, GDF5, and to lesser extent, NPC coculture -affect the gene expression profi le of human bone marrow derived MSCs in three dimensional alginate culture by induction of markers associated with an NP-like phenotype. However, the different stimuli infl uence different genes, although additive responses can be observed, e.g. by GDF5 under hypoxia. This may have implications for (i) in vitro differentiation of MSCs towards an NP-like phenotype and (ii) stimulation of endogenous progenitor cells after therapeutic application of GDF5 for IVD regenerative therapy. Further studies, including direct comparison with native disc cells, will be required to evaluate the potential of MSCs derived from bone marrow and other tissues (e.g. adipose) to approach an IVD-like phenotype.
